Clinical Trials

Drug Development Drug Efficacy Research Studies Phase 3 Trials Cancer Research Randomized Controlled Trials Animal Studies Experimental Treatments Phase 1 Trials Research Methodology

REGENXBIO Investors Face April 14 Deadline to Seek Lead Role in Securities Suit

Plaintiffs tie losses to FDA trial holds disclosed Jan. 28 after a reported tumor in a participant.

INSPIRE Trial Finds Prebiotic Inulin Eases Knee Osteoarthritis Pain

C-Further Launches First Pediatric Cancer Programs, Taps MiNK for PRAME iNKT Therapy

Breakthrough T1D Backs CAR-Treg Beta-Cell Therapy as UChicago Reports PD‑L1 mRNA Results

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

EU Regulators Back First Combined COVID-19 and Flu mRNA Shot for Adults 50 and Over

CRISPR Nutrigenomics Study Finds Vitamin B3 Rescues Fatal NAXD in Mice

Astellas–Vir Prostate Cancer Alliance Launches With New Data as VIR Stock Surges

p‑Tau217 Blood Tests Boost Alzheimer’s Diagnosis and Predict Onset Within a Few Years

Grail’s Galleri Test Misses Main Goal in Large NHS Trial

Single IV DMT Dose With Therapy Shows Rapid, Lasting Antidepressant Effect in Phase IIa Trial

Single IV Dose of DMT Shows Rapid, Lasting Antidepressant Effects in Small Trial

FDA Approves NovoCure’s Optune Pax for Locally Advanced Pancreatic Cancer

Bayer’s Asundexian Cuts Recurrent Stroke by 26% in Phase III Without Added Major Bleeding

Broad Flu Antibody Nasal Spray Shows Safety and Strong Nasal Neutralization in Phase 1

Pfizer’s Monthly Obesity Shot Shows Mid-Stage Gains With Up to 12.3% Weight Loss

Triple Therapy Eradicates Pancreatic Tumors in Mice in CNIO Study

Genentech Licenses SanegeneBio RNAi Program in Deal Worth Up to $1.7 Billion

Three-Drug KRAS Strategy Eradicates Pancreatic Tumors in Mice, CNIO Study Finds

Low-Dose THC Paired With Celecoxib Improves Cognition and Alzheimer’s Pathology in Mice